119 related articles for article (PubMed ID: 22483194)
1. Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
Nakagawa T; Moriwaki K; Terao N; Nakagawa T; Miyamoto Y; Kamada Y; Miyoshi E
J Proteome Res; 2012 May; 11(5):2798-806. PubMed ID: 22483194
[TBL] [Abstract][Full Text] [Related]
2. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
[TBL] [Abstract][Full Text] [Related]
3. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
4. Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Nakagawa T; Takeishi S; Kameyama A; Yagi H; Yoshioka T; Moriwaki K; Masuda T; Matsumoto H; Kato K; Narimatsu H; Taniguchi N; Miyoshi E
J Proteome Res; 2010 Oct; 9(10):4888-96. PubMed ID: 20731380
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
6. Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells.
Muranaka M; Takamatsu S; Ouchida T; Kanazawa Y; Kondo J; Nakagawa T; Egashira Y; Fukagawa K; Gu J; Okamoto T; Kamada Y; Miyoshi E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108200
[TBL] [Abstract][Full Text] [Related]
7. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Noda K; Miyoshi E; Uozumi N; Yanagidani S; Ikeda Y; Gao C; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Hayashi N; Hori M; Taniguchi N
Hepatology; 1998 Oct; 28(4):944-52. PubMed ID: 9755230
[TBL] [Abstract][Full Text] [Related]
9. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
[TBL] [Abstract][Full Text] [Related]
10. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.
Nakagawa T; Uozumi N; Nakano M; Mizuno-Horikawa Y; Okuyama N; Taguchi T; Gu J; Kondo A; Taniguchi N; Miyoshi E
J Biol Chem; 2006 Oct; 281(40):29797-806. PubMed ID: 16899455
[TBL] [Abstract][Full Text] [Related]
11. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
[TBL] [Abstract][Full Text] [Related]
12. The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
Noda K; Miyoshi E; Kitada T; Nakahara S; Gao CX; Honke K; Shiratori Y; Moriwaki H; Sasaki Y; Kasahara A; Hori M; Hayashi N; Taniguchi N
Tumour Biol; 2002; 23(4):202-11. PubMed ID: 12499776
[TBL] [Abstract][Full Text] [Related]
13. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
[TBL] [Abstract][Full Text] [Related]
14. Biological function of fucosylation in cancer biology.
Miyoshi E; Moriwaki K; Nakagawa T
J Biochem; 2008 Jun; 143(6):725-9. PubMed ID: 18218651
[TBL] [Abstract][Full Text] [Related]
15. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Nakagawa T; Miyoshi E; Yakushijin T; Hiramatsu N; Igura T; Hayashi N; Taniguchi N; Kondo A
J Proteome Res; 2008 Jun; 7(6):2222-33. PubMed ID: 18479159
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells.
Ohyama C; Smith PL; Angata K; Fukuda MN; Lowe JB; Fukuda M
J Biol Chem; 1998 Jun; 273(23):14582-7. PubMed ID: 9603974
[TBL] [Abstract][Full Text] [Related]
17. The expression of core fucosylated E-cadherin in cancer cells and lung cancer patients: prognostic implications.
Geng F; Shi BZ; Yuan YF; Wu XZ
Cell Res; 2004 Oct; 14(5):423-33. PubMed ID: 15538974
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a fucosylated α-fetoprotein-specific monoclonal antibody: a potential application for clinical research.
Egashira Y; Suganuma M; Kataoka Y; Higa Y; Ide N; Morishita K; Kamada Y; Gu J; Fukagawa K; Miyoshi E
Sci Rep; 2019 Aug; 9(1):12359. PubMed ID: 31451706
[TBL] [Abstract][Full Text] [Related]
19. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Takayama H; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jul; 26(7):1195-200. PubMed ID: 21410750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
